Video
- Author:
- Sara Freeman
Publish date: August 11, 2017
MADRID – New data confirm that triple therapy with anticoagulation, corticosteroids, and plasma exchange or intravenous immunoglobulins increases C...
News
- Author:
- Sara Freeman
Publish date: July 25, 2017
MADRID – About one-third of RA patients were nonadherent to methotrexate at the time they were eligible to start biologic therapy in one survey.
News
- Author:
- Sara Freeman
Publish date: July 24, 2017
MADRID – Two experimental therapies show promise as future alternatives to current therapies.
News
- Author:
- Sara Freeman
Publish date: July 17, 2017
MADRID – The investigational drug met none of its primary, secondary, or exploratory endpoints.
News
- Author:
- Sara Freeman
Publish date: July 13, 2017
MADRID – A regimen of methotrexate plus a tapering prednisone dose may have the best benefit-to-risk profile over 2 years.
News
- Author:
- Sara Freeman
Publish date: July 13, 2017
MADRID – Real-world results provide some insight on different doses but still leave questions.
News
- Author:
- Sara Freeman
Publish date: July 11, 2017
MADRID – Could time to RA remission be shortened and sustained?
Video
- Author:
- Sara Freeman
Publish date: July 10, 2017
MADRID – Since 2000, the risk ratios for several CV events have declined.
News
- Author:
- Sara Freeman
Publish date: July 10, 2017
MADRID – Bone health could be assessed earlier using FRAX, ideally at or before the time of the transplant.
News
- Author:
- Sara Freeman
Publish date: July 10, 2017
MADRID – Risk highest among those aged 40-65 years.
News
- Author:
- Sara Freeman
Publish date: June 30, 2017
MADRID – A simple intervention led to a discussion between a nurse and a patient about the benefits and risks of being vaccinated.
News
- Author:
- Sara Freeman
Publish date: June 30, 2017
MADRID – Findings from phase IIIB/IV ORAL Strategy study verify the safety and effectiveness of tofacitinib as a non–tumor necrosis factor inhibito...
Video
- Author:
- Sara Freeman
Publish date: June 28, 2017
MADRID – Rather than measuring anti-drug antibodies, the future points more toward using drug trough levels to guide treatment decisions.
News
- Author:
- Sara Freeman
Publish date: June 25, 2017
MADRID – Biosimilar adalimumab and etanercept are no more immunogenic than their reference counterparts.
Video
- Author:
- Sara Freeman
Publish date: June 19, 2017
MADRID – A few serious cases of hypersensitivity were the only concerns.
